---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-023779"
form_type: "8-K"
ticker: "AYTU"
cik: "0001385818"
company_name: "AYTU BIOPHARMA, INC"
filed_at: "2023-02-21T23:59:59+00:00"
generated_at: "2026-06-19T06:43:24.881460+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Aytu BioPharma restates Q1 FY2023 financials; warrant misclassification adds $5.6M liabilities

## Summary
- Audit committee concludes Sep 30, 2022 financials should be restated due to warrant misclassification as equity instead of liabilities.
- Restatement increases total liabilities by $5.6M, decreases equity by $3.4M, and reduces net loss by $2.2M.
- Material weakness in internal control over financial reporting identified; company working to remediate.
- Company expects to file 10-Q/A for Sep quarter and then 10-Q for Dec quarter as soon as practicable.
- Going forward, warrants will be classified as liabilities, which may adversely affect results of operations.

## SEC filing metadata
- accession: 0001104659-23-023779
- form_type: 8-K
- ticker: AYTU
- cik: 0001385818
- company_name: AYTU BIOPHARMA, INC
- filed_at: 2023-02-21T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 4.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1385818/000110465923023779/0001104659-23-023779-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1385818/000110465923023779/tm237439d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-023779
- JSON: https://secwatch.observer/filing/0001104659-23-023779.json
- Plain text: https://secwatch.observer/filing/0001104659-23-023779.txt

## Key facts
- Auditor Changes
  AYTU BIOPHARMA, INC reported that prior financial statements should not be relied upon.
  - Action: non reliance
  source text: and, accordingly, that such previously issued financial statements should no longer be relied upon
  evidence_url: https://www.sec.gov/Archives/edgar/data/1385818/000110465923023779/0001104659-23-023779-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.